Unique ID issued by UMIN | UMIN000049403 |
---|---|
Receipt number | R000056250 |
Scientific Title | Prospective observational study on the impact of vaccination against COVID19 in patients with cancer |
Date of disclosure of the study information | 2022/11/02 |
Last modified on | 2022/11/04 14:28:35 |
Prospective observational study on the impact of vaccination against COVID19 in patients with cancer
Prospective observational study on the impact of vaccination against COVID19 in patients with cancer
Prospective observational study on the impact of vaccination against COVID19 in patients with cancer
Prospective observational study on the impact of vaccination against COVID19 in patients with cancer
Japan |
cancer
Medicine in general |
Malignancy
NO
Blood samples will be collected from patients with cancer at the National Cancer Center Hospital after vaccination for COVID-19 to determine the prevalence of SARS-CoV-2 antibodies. We will examine the influence of the background of the carcinoma patients (cancer type, stage, treatment, etc.) on the efficacy of COVID-19 vaccine.
Safety,Efficacy
Exploratory
SARS-CoV-2 antibody positivity after 2 doses of vaccine
Observational
16 | years-old | <= |
100 | years-old | > |
Male and Female
1) Age 16 years or older at the time of consent
2) Patients with cancer at the National Cancer Center Hospital (regardless of cancer type or stage)
3) Have blood samples taken at this hospital at least once every three months.
4) Adults whose written consent for this study has been obtained by the patient, or minors whose written consent for this study has been obtained by the patient
5) Scheduled to receive COVID-19 vaccine or within approximately 6 months of the second (or last) dose of the vaccine
Subjects who are determined by the principal investigator or physician in charge to be inappropriate as subjects for this study
1000
1st name | Yuki |
Middle name | |
Last name | Katsuya |
National cancer center hospital
Department of experimental development
104-0045
5-1-1, Tsukiji, Chuo-ku, Tokyo
03-3542-2511
ykatsuya@ncc.go.jp
1st name | Yuki |
Middle name | |
Last name | Katsuya |
National Cancer Center Hospital
Department of experimental development
104-0045
5-1-1, Tsukiji, Chuo-ku, Tokyo
03-3542-2511
ykatsuya@ncc.go.jp
National cancer center hospital
National cancer center hospital
Self funding
National cancer center
5-1-1, Tsukiji, Chuo-ku
03-3542-2511
irst@ml.res.ncc.go.jp
YES
2020-582
Natinal cancer center
2022 | Year | 11 | Month | 02 | Day |
Unpublished
589
No longer recruiting
2021 | Year | 03 | Month | 04 | Day |
2021 | Year | 03 | Month | 31 | Day |
2021 | Year | 03 | Month | 31 | Day |
2022 | Year | 12 | Month | 31 | Day |
Patient enrollment completed, under follow-up
2022 | Year | 11 | Month | 02 | Day |
2022 | Year | 11 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056250
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |